In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
Brought to you by

Latest Inception Sciences experiment to tackle MS; Roche has option to buy Inception 5; exercised

Executive Summary

Roche signed an exclusive funding and option-to-acquire deal with Inception Sciences Inc. (incubator involved in drug discovery) and its new spin-off Inception 5 Inc., focused on multiple sclerosis.
Deal Industry
  • Pharmaceuticals
  • Biotechnology
    • Gene Therapy, Cell Therapy
Deal Status
  • Final
Deal Type
  • Alliance
    • Includes M&A Option
    • R&D and Marketing (Licensing)

Related Companies

UsernamePublicRestriction

Register